Shopping Cart
Remove All
Your shopping cart is currently empty
Mal-amido-PEG2-C2-amido-Ph-C2-CO-AZD (PF-05231023) is a long-acting fibroblast growth factor 21 (FGF21) analog and FGF21-receptor agonist, suitable for development as a potential treatment for T2DM.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 5 mg | $46 | In Stock | In Stock | |
| 10 mg | $73 | In Stock | In Stock | |
| 25 mg | $137 | In Stock | In Stock | |
| 50 mg | $223 | In Stock | In Stock | |
| 100 mg | $358 | In Stock | In Stock | |
| 1 mL x 10 mM (in DMSO) | $59 | In Stock | In Stock |
| Description | Mal-amido-PEG2-C2-amido-Ph-C2-CO-AZD (PF-05231023) is a long-acting fibroblast growth factor 21 (FGF21) analog and FGF21-receptor agonist, suitable for development as a potential treatment for T2DM. |
| In vitro | PF-05231023 is a analog of long-acting fibroblast growth factor 21 [2]. |
| In vivo | Mal-amido-PEG2-C2-amido-Ph-C2-CO-AZDsuppresses oxidative-stress-induced inflammation in photoreceptors. Mal-amido-PEG2-C2-amido-Ph-C2-CO-AZDdecreases the variability of retinal NRF2 levels and displays a trend (non-significant) towards increased NRF2 levels in Akita mice. Mal-amido-PEG2-C2-amido-Ph-C2-CO-AZDdecreases retinal IL-1β mRNA expression in Akita mice. Mal-amido-PEG2-C2-amido-Ph-C2-CO-AZDenhances cone-specific arrestin4 expression in Akita mice. Mal-amido-PEG2-C2-amido-Ph-C2-CO-AZDrestores photoreceptor morphology in Akita mice. Administration of native FGF21 and Mal-amido-PEG2-C2-amido-Ph-C2-CO-AZD(3mg/kg or 10mg/kg; subcutaneously twice a week for two weeks) improves glucose tolerance and liver insulin sensitivity in Zucker rats. Mal-amido-PEG2-C2-amido-Ph-C2-CO-AZD(10 mg/kg; intraperitoneally injected) reduces retinal inflammation in diabetic mice [3][4]. |
| Synonyms | PF-05231023 |
| Molecular Weight | 528.55 |
| Formula | C26H32N4O8 |
| Cas No. | 1037589-69-7 |
| Smiles | O=C(CCN1C(=O)C=CC1=O)NCCOCCOCCC(=O)Nc1ccc(CCC(=O)N2CCC2=O)cc1 |
| Relative Density. | 1.345 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 125 mg/mL (236.5 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 4 mg/mL (7.57 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.